Cargando…

Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions

Glioblastoma is a highly aggressive form of brain cancer characterized by the abundance of myeloid lineage cells in the tumor microenvironment. Tumor-associated macrophages and microglia (TAM) and myeloid-derived suppressor cells (MDSCs), play a pivotal role in promoting immune suppression and tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Junfeng, Piranlioglu, Raziye, Ye, Fei, Shu, Kai, Lei, Ting, Nakashima, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206241/ https://www.ncbi.nlm.nih.gov/pubmed/37234776 http://dx.doi.org/10.3389/fcimb.2023.1141034

Ejemplares similares

Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
por: Wu, Yi-Ying, et al.
Publicado: (2023)

Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020)

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
por: Qi, Zhongbing, et al.
Publicado: (2022)

Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
por: Kardani, Kimia, et al.
Publicado: (2023)

ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012)

Combining HDAC inhibitors with oncolytic virotherapy for cancer therapy
por: Nakashima, Hiroshi, et al.
Publicado: (2015)

Editorial: ESKAPE biofilm: challenges and solutions
por: Tiwari, Vishvanath
Publicado: (2023)

Oncolytic virotherapy reverses the immunosuppressive tumor microenvironment and its potential in combination with immunotherapy
por: Zhang, Yalei, et al.
Publicado: (2021)

Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors
por: Li, Qingbo, et al.
Publicado: (2022)

Editorial: Recent advances in oncolytic virus therapy for brain tumors
por: Askari, Fatemeh Sana, et al.
Publicado: (2023)

Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements
por: Jin, Ke-Tao, et al.
Publicado: (2021)

Progress of oncolytic virotherapy for neuroblastoma
por: Chen, Xiao-Tong, et al.
Publicado: (2022)

Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)

Editorial: Oncolytic virotherapy
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2023)

Experimental infection of non-immunosuppressed and immunosuppressed goats reveals differential pathogenesis of Babesia aktasi n. sp.
por: Ozubek, Sezayi, et al.
Publicado: (2023)

IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma
por: Chen, Xueqin, et al.
Publicado: (2023)

Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
por: Webb, Mason J., et al.
Publicado: (2023)

Pediatric glioma stem cells: biologic strategies for oncolytic HSV virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2013)

Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice
por: Auffinger, Brenda, et al.
Publicado: (2013)

Immune Suppression during Oncolytic Virotherapy for High-Grade Glioma; Yes or No?
por: Koks, Carolien A.E., et al.
Publicado: (2015)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Oncolytic virotherapy – in vivo veritas
por: Kemler, Iris, et al.
Publicado: (2018)

Delivery and Biosafety of Oncolytic Virotherapy
por: Li, Lizhi, et al.
Publicado: (2020)

Oncolytic Virotherapy with Myxoma Virus
por: Rahman, Masmudur M., et al.
Publicado: (2020)

Syncytia Formation in Oncolytic Virotherapy
por: Burton, Chase, et al.
Publicado: (2019)

Editorial: Challenges and solutions for the incomplete immune restoration in HIV-infected patients under antiretroviral therapy
por: Kuang, Yi-Qun, et al.
Publicado: (2023)

Identification of pyrC gene as an immunosuppressive factor in Francisella novicida infection
por: Nakamura, Takemasa, et al.
Publicado: (2022)

Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements
por: Shao, Su, et al.
Publicado: (2022)

Opportunities and challenges of combining adoptive cellular therapy with oncolytic virotherapy
por: Mamola, Joseph A., et al.
Publicado: (2023)

Toxoplasma gondii infection possibly reverses host immunosuppression to restrain tumor growth
por: Chen, Jiating, et al.
Publicado: (2022)

Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models
por: Berthold, Emilia J., et al.
Publicado: (2022)

ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas
por: Li, Jinchuan, et al.
Publicado: (2022)

Deep learning of magnetic resonance fingerprints for the quantitative imaging of apoptosis following oncolytic virotherapy
por: Perlman, Or, et al.
Publicado: (2022)

Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions
por: Holbrook, Molly C., et al.
Publicado: (2021)

Clinical Characteristics of Bloodstream Infection in Immunosuppressed Patients: A 5-Year Retrospective Cohort Study
por: Lin, Hongxia, et al.
Publicado: (2022)

Oncolytic Virotherapy of Canine and Feline Cancer
por: Gentschev, Ivaylo, et al.
Publicado: (2014)

Oncolytic virotherapy for advanced liver tumours
por: Chang, Ju-Fang, et al.
Publicado: (2009)

The Practical Consideration of Poliovirus as an Oncolytic Virotherapy
por: Denniston, Elizabeth, et al.
Publicado: (2016)

Measles virus: Background and oncolytic virotherapy
por: Bhattacharjee, Sankhajit, et al.
Publicado: (2018)

Multidisciplinary oncolytic virotherapy for gastrointestinal cancer
por: Fujiwara, Toshiyoshi
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hckpmoli97h3o2danljinfeq99